DEF 14A: Monogram Technologies Inc. Announces 2024 Annual Meeting of Stockholders

Monogram Technologies Inc. will hold its 2024 Annual Meeting of Stockholders virtually on December 19, 2024, to vote on director elections, auditor ratification, an amendment to the stock option plan, and executive compensation.

Summary

• Monogram Technologies Inc. is holding its 2024 Annual Meeting of Stockholders on December 19, 2024, at 1:00 p.m. Eastern Standard Time, via a live audio webcast.
• Stockholders of record as of October 25, 2024, are entitled to vote on several key proposals.
• The proposals include the election of Class I directors (Rick Van Kirk and Colleen Gray) for a three-year term expiring in 2027, the ratification of Fruci & Associates II, PLLC as the independent registered public accounting firm for the year ending December 31, 2024, and the approval of an amendment to the Amended and Restated 2019 Stock Option and Grant Plan.
• Additionally, stockholders will vote on an advisory basis regarding the compensation of the company's named executive officers.
• The Board of Directors recommends voting 'FOR' all director nominees and proposals.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The proposals are routine and the Board's recommendations are clear, suggesting a stable outlook.

Positives

• The proposed amendment to the 2019 Stock Option and Grant Plan aims to attract, motivate, and retain key personnel by offering competitive equity-based compensation.
• The Board believes that the proposed changes to the stock option plan are cost-efficient and will help align the interests of participants with those of the stockholders.
• The company is providing access to proxy materials via the internet to lower costs and reduce environmental impact.

Negatives

• Approval of the amendment to the Amended and Restated 2019 Stock Option and Grant Plan will result in potential dilution to existing stockholders.
• The company is in discussions with Mount Sinai regarding a payment obligation associated with becoming publicly traded on Nasdaq, which may require a payment or a senior note.

Risks

• Failure to meet the first commercial sale deadline with Mount Sinai by October 3, 2025, could lead to a breach of the License Agreement.
• The company faces risks related to the supply agreement with Pro-Dex, including potential termination if Pro-Dex fails to fulfill purchase orders.
• The company's success depends on attracting and retaining high-quality officers, employees, consultants, and directors.

Future Outlook

The company aims to continue attracting and retaining high-quality officers, employees, consultants, and directors to support its growth and success.

Industry Context

The document reflects standard corporate governance practices for publicly traded companies, including holding annual meetings, soliciting proxies, and disclosing executive compensation and related party transactions.

Comparison to Industry Standards

• The director independence criteria align with Nasdaq listing requirements.
• The company's compensation practices are designed to attract and retain talented executives in a competitive environment.
• The disclosure of related party transactions is consistent with SEC regulations.

Related Party Transactions

• The company has an Exclusive License Agreement with Icahn School of Medicine at Mount Sinai, which is affiliated with one of the directors, Doug Unis.
• The company has a supply agreement with Pro-Dex, Inc., where Richard L. Van Kirk, a director of Monogram, is the Chief Executive Officer.
• Pro-Dex exercised warrants to purchase Common Stock of Monogram, resulting in the issuance of 1,828,551 shares.

Stakeholder Impact

• Shareholders are asked to vote on matters that will impact the company's governance, compensation practices, and financial performance.
• Employees may be affected by changes to the stock option plan.
• The company's relationships with Mount Sinai and Pro-Dex impact its operations and financial obligations.

Next Steps

• Stockholders are encouraged to review the proxy materials and vote as soon as possible.
• The company will announce preliminary voting results at the Annual Meeting and publish final results in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Auditor Ratification, Executive Compensation, Stock Option Plan, Monogram Technologies, Corporate Governance